primaquine has been researched along with Chronic Illness in 13 studies
Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Primaquine was effective in preventing P." | 5.72 | Relapse of Plasmodium vivax and Plasmodium ovale Malaria With and Without Primaquine Treatment in a Nonendemic Area. ( Björklund, D; Carlander, C; Färnert, A; Hellgren, U; Hervius Askling, H; Sondén, K; Stenström, C; Wångdahl, A; Wyss, K; Zhang, J, 2022) |
| "This suggested that 32 of the 47 recurrences were probable relapses of which 22 (69%) were genetically homologous." | 2.77 | Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata. ( Addy, M; Day, NP; Dondorp, AM; Imwong, M; Kim, JR; Maji, AK; Nandy, A; Pukrittayakamee, S; White, NJ, 2012) |
| "Primaquine was effective in preventing P." | 1.72 | Relapse of Plasmodium vivax and Plasmodium ovale Malaria With and Without Primaquine Treatment in a Nonendemic Area. ( Björklund, D; Carlander, C; Färnert, A; Hellgren, U; Hervius Askling, H; Sondén, K; Stenström, C; Wångdahl, A; Wyss, K; Zhang, J, 2022) |
| "vivax malaria were randomized to receive chloroquine (CQ; 25 mg base/kg given over 3 days) alone or together with primaquine (PQ; 0." | 1.51 | Efficacy of Primaquine in Preventing Short- and Long-Latency Plasmodium vivax Relapses in Nepal. ( Adhikari, B; Banjara, MR; Chotivanich, K; Das Thakur, G; Day, NPJ; Ghimire, P; Hanboonkunupakarn, B; Imwong, M; Pukrittayakamee, S; Rijal, KR; White, NJ, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Gandrala, D | 2 |
| Gupta, N | 2 |
| Lavu, A | 2 |
| Nallapati, VT | 2 |
| Guddattu, V | 2 |
| Saravu, K | 2 |
| Chamma-Siqueira, NN | 1 |
| Viana, GMR | 1 |
| Macedo de Oliveira, A | 1 |
| Wångdahl, A | 1 |
| Sondén, K | 1 |
| Wyss, K | 1 |
| Stenström, C | 1 |
| Björklund, D | 1 |
| Zhang, J | 1 |
| Hervius Askling, H | 1 |
| Carlander, C | 1 |
| Hellgren, U | 1 |
| Färnert, A | 1 |
| Sümer, Ş | 1 |
| Aktuğ Demir, N | 1 |
| Ural, O | 1 |
| Çimen, G | 1 |
| Yalçınkaya, E | 1 |
| Rijal, KR | 1 |
| Adhikari, B | 1 |
| Ghimire, P | 1 |
| Banjara, MR | 1 |
| Das Thakur, G | 1 |
| Hanboonkunupakarn, B | 1 |
| Imwong, M | 2 |
| Chotivanich, K | 1 |
| Day, NPJ | 1 |
| White, NJ | 2 |
| Pukrittayakamee, S | 2 |
| Rosenthal, PJ | 1 |
| Kim, JR | 1 |
| Nandy, A | 1 |
| Maji, AK | 1 |
| Addy, M | 1 |
| Dondorp, AM | 1 |
| Day, NP | 1 |
| HANSEN, JE | 1 |
| CLEVE, EA | 1 |
| PRUITT, FW | 1 |
| ARNOLD, J | 1 |
| ALVING, AS | 1 |
| HOCKWALD, RS | 1 |
| CLAYMAN, CB | 1 |
| DERN, RJ | 1 |
| BEUTLER, E | 1 |
| JEFFERY, GM | 1 |
| Trier, JS | 1 |
| Moxey, PC | 1 |
| Schimmel, EM | 1 |
| Robles, E | 1 |
| Fisher, GU | 1 |
| Gordon, MP | 1 |
| Lobel, HO | 1 |
| Runcik, K | 1 |
| Wilks, NE | 1 |
| Turner, PP | 1 |
| Somers, K | 1 |
| Markandya, OP | 1 |
| Wiseman, RA | 1 |
1 trial available for primaquine and Chronic Illness
| Article | Year |
|---|---|
Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Chronic Disease; Female; Genotype; Genotyping Techniq | 2012 |
12 other studies available for primaquine and Chronic Illness
| Article | Year |
|---|---|
Recurrence in
Topics: Adult; Antimalarials; Chronic Disease; Follow-Up Studies; Humans; India; Malaria, Vivax; Plasmodium | 2022 |
Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria. Reply.
Topics: Antimalarials; Chronic Disease; Humans; Malaria, Vivax; Plasmodium vivax; Primaquine; Recurrence | 2022 |
Relapse of Plasmodium vivax and Plasmodium ovale Malaria With and Without Primaquine Treatment in a Nonendemic Area.
Topics: Antimalarials; Chronic Disease; Humans; Malaria; Malaria, Vivax; Plasmodium ovale; Plasmodium vivax; | 2022 |
A Malaria Case Followed By Relapse.
Topics: Animals; Anopheles; Antimalarials; Chronic Disease; Diagnosis, Differential; Humans; Malaria, Vivax; | 2018 |
Efficacy of Primaquine in Preventing Short- and Long-Latency Plasmodium vivax Relapses in Nepal.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Chronic Disease; Drug Therapy, Combination; Female; F | 2019 |
A shorter course for anti-relapse therapy against vivax malaria.
Topics: Antimalarials; Chronic Disease; Humans; Malaria, Vivax; Primaquine; Recurrence | 2019 |
Relapse of vivax malaria treated with primaquine and report of one case of cyanosis (methemoglobinemia) due to primaquine.
Topics: Antimalarials; Chronic Disease; Cyanosis; Humans; Malaria; Malaria, Vivax; Methemoglobinemia; Primaq | 1954 |
The effect of continuous and intermittent primaquine therapy on the relapse rate of Chesson strain vivax malaria.
Topics: Antimalarials; Chronic Disease; Humans; Malaria; Malaria, Vivax; Primaquine; Recurrence | 1954 |
Chronic intestinal coccidiosis in man: intestinal morphology and response to treatment.
Topics: Antiprotozoal Agents; Biopsy; Chloroquine; Chronic Disease; Coccidiosis; Diagnosis, Differential; Di | 1974 |
Malaria in soldiers returning from Vietnam. Epidemiologic, therapeutic, and clinical studies.
Topics: Adult; Black or African American; Black People; Chloroquine; Chronic Disease; Hospitalization; Human | 1970 |
Chronic ill-health from unrecognized malaria.
Topics: Adult; Africa, Eastern; Arrhythmias, Cardiac; Chronic Disease; Female; Fluorescent Antibody Techniqu | 1965 |
Relapse after standard treatment of malaria.
Topics: Adult; Chloroquine; Chronic Disease; Humans; Malaria; Male; Primaquine | 1970 |